Preferred Label : Multiple endocrine neoplasia, type I;
Symbol : MEN1;
CISMeF acronym : MEN1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Men I; Endocrine adenomatosis, multiple; Mea I; Wermer syndrome;
Included titles and symbols : Men1 somatic mutations;
Description : Multiple endocrine neoplasia type I (MEN1) is an autosomal dominant disorder characterized
by varying combinations of tumors of parathyroids, pancreatic islets, duodenal endocrine
cells, and the anterior pituitary, with 94% penetrance by age 50. Less commonly associated
tumors include foregut carcinoids, lipomas, angiofibromas, thyroid adenomas, adrenocortical
adenomas, angiomyolipomas, and spinal cord ependymomas. Except for gastrinomas, most
of the tumors are nonmetastasizing, but many can create striking clinical effects
because of the secretion of endocrine substances such as gastrin, insulin, parathyroid
hormone, prolactin, growth hormone, glucagon, or adrenocorticotropic hormone (summary
by Chandrasekharappa et al., 1997). - Genetic Heterogeneity of Multiple Endocrine
Neoplasia Other forms of multiple endocrine neoplasia include MEN2A (171400) and MEN2B
(162300), both of which are caused by mutation in the RET gene (164761), and MEN4
(610755), which is caused by mutation in the CDKN1B gene (600778).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutations in the menin gene (MEN1, 131100.0001);
Neoplasia : Carcinoid tumors;
Laboratory abnormalities : Elevated ACTH; Abnormal secretin test; Elevated gastrin concentration; Hypercalcemia; Hypoglycemia; Elevated PTH (parathyroid hormone);
Prefixed ID : #131100;
Origin ID : 131100;
UMLS CUI : C0025267;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
NCIt concept(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT